News & Events

Latest News

October 7, 2021

Inhalon Doses First Patient in Phase 1 Study of Inhaled IN‑006 to Treat COVID-19  Read More

July 22, 2021

Inhalon Collaborates with Celltrion, Inc. to Develop Nebulized Form of Regdanvimab to Treat COVID-19 Patients at Home  Read More

July 16, 2021

Inhalon Biopharma Appoints Jeff Hutchins, Ph.D. as Chief Development Officer  Read More

May 26, 2021

Inhalon Biopharma Receives $7 Million from USAMRDC to Study Inhaled “Muco-trapping” Antibody for the Treatment of COVID-19  Read More

Events

No upcoming events at this time